Vanda Pharmaceuticals (VNDA) Interest Coverage Ratio Growth (5y) (2015 - 2026)
Vanda Pharmaceuticals (VNDA) Interest Coverage Ratio Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vanda Pharmaceuticals | 318.71 Mn | 116.40 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -56.23% |
| Dec 31, 2025 | -64.62% |
| Sep 30, 2025 | -61.61% |
| Jun 30, 2025 | -39.30% |
| Mar 31, 2025 | -274.12% |
| Dec 31, 2024 | -16.98% |
| Sep 30, 2024 | -38.10% |
| Jun 30, 2024 | -38.66% |
| Mar 31, 2024 | -60.66% |
| Dec 31, 2023 | -64.80% |
| Sep 30, 2023 | -105.23% |
| Jun 30, 2023 | -80.37% |
| Mar 31, 2023 | 72.95% |
| Dec 31, 2022 | 120.54% |
| Sep 30, 2022 | 71.48% |
| Jun 30, 2022 | 86.67% |
| Mar 31, 2022 | -47.23% |
| Dec 31, 2021 | 207.84% |
| Sep 30, 2021 | 105.66% |
| Jun 30, 2021 | 30.11% |